Estrodose (Oestrodose) by Besins Healthcare is transdermal 17-beta-estradiol gel 0.06% with a metered pump - the original French menopause therapy. Each pump press delivers 1.25 g of gel containing 0.75 mg estradiol; the 80 g bottle provides 64 doses.
Composition
Why a transdermal gel
Estradiol applied to the skin passes directly into the bloodstream, bypassing first-pass liver metabolism - the same principle as in patches, but with flexible dosing. The pump allows precise adjustment: from 1 to 4 doses per day, per the physician scheme. Transdermal estradiol is associated with a lower venous thrombosis risk profile than oral estrogens in modern HRT practice.
Dosing (per instructions)
Where Estrodose is used
Product features
Contraindications
Known or suspected hormone-dependent tumors; undiagnosed genital bleeding; active thromboembolic disease; severe liver disorders; hypersensitivity. HRT requires physician evaluation with annual benefit/risk review.
FAQ
Both are Besins estradiol gels with the same 0.06% concentration and the same 1.25 g/0.75 mg pump dose. Estrodose (Oestrodose) is the French-market presentation; Oestrogel is the international brand. Same molecule, same dosing math.
If the uterus is intact - yes: estrogen alone stimulates endometrial growth, so progesterone (e.g., Progestan micronized capsules) is combined per the HRT scheme. After hysterectomy, estrogen monotherapy is typically prescribed.
Arms, shoulders or thighs - rotating sites daily. Not on the breasts, face or irritated skin. Apply once daily after showering, let it dry for a few minutes.
Let the gel dry and cover the area; estradiol can transfer by skin contact - avoid direct skin-to-skin contact with the application site, especially with children or pets, until the skin is covered or washed.
Hot flushes usually improve within the first 2 weeks of correct dosing; full symptom assessment and dose adjustment are done after 2-3 months per the HRT schedule.
Ask a question or inquire about delivery to your country
